FR22C1003I1 - - Google Patents
Info
- Publication number
- FR22C1003I1 FR22C1003I1 FR22C1003C FR22C1003I1 FR 22C1003 I1 FR22C1003 I1 FR 22C1003I1 FR 22C1003 C FR22C1003 C FR 22C1003C FR 22C1003 I1 FR22C1003 I1 FR 22C1003I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34837610P | 2010-05-26 | 2010-05-26 | |
PCT/SE2011/050652 WO2011149419A1 (en) | 2010-05-26 | 2011-05-25 | Vaccine against streptococcal infections based on recombinant proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
FR22C1003I1 true FR22C1003I1 (es) | 2022-02-18 |
FR22C1003I2 FR22C1003I2 (fr) | 2023-02-03 |
Family
ID=45004197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR22C1003C Active FR22C1003I2 (fr) | 2010-05-26 | 2022-01-12 | Vaccin contre des infections streptococciques base sur des proteines de recombinaison |
Country Status (10)
Country | Link |
---|---|
US (2) | US9333252B2 (es) |
EP (2) | EP3135684B1 (es) |
CN (1) | CN103068838B (es) |
AU (1) | AU2011258898B2 (es) |
CA (1) | CA2799136A1 (es) |
ES (2) | ES2948841T3 (es) |
FR (1) | FR22C1003I2 (es) |
HK (1) | HK1183677A1 (es) |
NL (1) | NL301156I2 (es) |
WO (1) | WO2011149419A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011059385A1 (en) * | 2009-11-13 | 2011-05-19 | Bengt Guss | Immunizing composition for reducing streptococcal infections |
EP2949340A1 (en) * | 2014-05-30 | 2015-12-02 | IDT Biologika GmbH | Vaccine composition against Streptococcus suis infection |
GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
GB201502306D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
CN104789587B (zh) * | 2015-04-10 | 2018-04-27 | 新疆农业大学 | 重组真核表达质粒复合物在制备马腺疫链球菌疫苗的应用 |
CN115443288A (zh) * | 2020-06-18 | 2022-12-06 | 上海宝济药业有限公司 | 一种免疫球蛋白降解酶IdeE的突变体 |
CN112011479B (zh) * | 2020-08-06 | 2022-04-22 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 马链球菌马亚种hlj2018d-lx株及其在制备马链球菌马亚种灭活疫苗中的应用 |
CN114437235B (zh) * | 2022-01-04 | 2024-02-09 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用 |
WO2024112492A1 (en) * | 2022-11-22 | 2024-05-30 | Duke University | Compositions comprising antibody cleaving enzymes and method of using the same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR241545A1 (es) | 1985-07-12 | 1992-08-31 | Cornell Res Foundation Inc | Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos. |
US5583014A (en) | 1990-07-03 | 1996-12-10 | Bayer Corporation | Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine |
SE9302855D0 (sv) | 1993-09-06 | 1993-09-06 | Martin Lindberg | Method and means for producing plasmaproteinase inhibitor binding proteins |
IES960488A2 (en) | 1996-07-03 | 1997-11-19 | Trinity College Dublin | Subunit Vaccine for Streptococcus Equi |
FR2750999B1 (fr) | 1996-07-10 | 1998-11-20 | Appligene Oncor | Adn polymerase thermostable d'archaebacteries du genre pyrococcus sp |
SE9804491D0 (sv) | 1998-12-22 | 1998-12-22 | Bengt Guss | Novel fibronectin-binding protein |
ATE471156T1 (de) * | 2002-10-11 | 2010-07-15 | Bengt Guss | Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi |
CA2647566C (en) | 2006-03-29 | 2017-01-03 | Merial Limited | Vaccine against streptococci |
GB0624874D0 (en) | 2006-12-13 | 2007-01-24 | Hansa Medical Ab | Treatment |
EP2190984B1 (en) | 2007-09-14 | 2013-09-04 | Genovis Ab | Methods and kits for purification and detection of glycosylated IgG |
EP2227249B1 (en) * | 2007-12-13 | 2018-04-25 | Intervacc AB | Improved immunizing composition |
GB0801326D0 (en) | 2008-01-24 | 2008-03-05 | Animal Health Trust | Vaccines |
AU2010204139A1 (en) | 2009-01-12 | 2011-08-11 | Novartis Ag | Cna_B domain antigens in vaccines against gram positive bacteria |
WO2011059385A1 (en) | 2009-11-13 | 2011-05-19 | Bengt Guss | Immunizing composition for reducing streptococcal infections |
-
2011
- 2011-05-25 EP EP16193491.4A patent/EP3135684B1/en active Active
- 2011-05-25 WO PCT/SE2011/050652 patent/WO2011149419A1/en active Application Filing
- 2011-05-25 CN CN201180026088.9A patent/CN103068838B/zh active Active
- 2011-05-25 ES ES16193491T patent/ES2948841T3/es active Active
- 2011-05-25 US US13/683,522 patent/US9333252B2/en active Active
- 2011-05-25 ES ES11786995.8T patent/ES2612520T3/es active Active
- 2011-05-25 EP EP11786995.8A patent/EP2590994B1/en active Active
- 2011-05-25 AU AU2011258898A patent/AU2011258898B2/en active Active
- 2011-05-25 CA CA2799136A patent/CA2799136A1/en not_active Abandoned
-
2013
- 2013-09-27 HK HK13111087.6A patent/HK1183677A1/zh unknown
-
2015
- 2015-12-04 US US14/959,672 patent/US9795664B2/en active Active
-
2021
- 2021-12-23 NL NL301156C patent/NL301156I2/nl unknown
-
2022
- 2022-01-12 FR FR22C1003C patent/FR22C1003I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
CN103068838B (zh) | 2016-03-02 |
WO2011149419A1 (en) | 2011-12-01 |
US20160082096A1 (en) | 2016-03-24 |
US9333252B2 (en) | 2016-05-10 |
ES2948841T3 (es) | 2023-09-20 |
FR22C1003I2 (fr) | 2023-02-03 |
NL301156I2 (nl) | 2022-03-11 |
EP2590994B1 (en) | 2016-11-02 |
CA2799136A1 (en) | 2011-12-01 |
US20130236469A1 (en) | 2013-09-12 |
EP2590994A4 (en) | 2014-04-30 |
EP2590994A1 (en) | 2013-05-15 |
ES2612520T3 (es) | 2017-05-17 |
EP3135684B1 (en) | 2023-06-28 |
EP3135684A1 (en) | 2017-03-01 |
HK1183677A1 (zh) | 2014-01-03 |
CN103068838A (zh) | 2013-04-24 |
AU2011258898A1 (en) | 2012-11-29 |
US9795664B2 (en) | 2017-10-24 |
EP3135684C0 (en) | 2023-06-28 |
AU2011258898B2 (en) | 2015-05-07 |